<DOC>
	<DOCNO>NCT00665054</DOCNO>
	<brief_summary>Purpose study : - To assess efficacy tolerability vardenafil male subject suffer erectile dysfunction compare placebo- To assess influence vardenafil self-esteem self-confidence subject suffer erectile dysfunction follow treatment vardenafil compare placebo</brief_summary>
	<brief_title>BAY38-9456 , 5/10/20mg , vs.Placebo Erectile Dysfunction</brief_title>
	<detailed_description />
	<mesh_term>Erectile Dysfunction</mesh_term>
	<mesh_term>Vardenafil Dihydrochloride</mesh_term>
	<criteria>Men heterosexual relationship age 18 64 year suffer ED 6 month accord NIH Consensus Statement ( i.e . inability attain and/or maintain penile erection sufficient satisfactory sexual performance ) . At least 4 attempt sexual intercourse ( accord question subject diary ) 4 separate day 4week untreated baseline period . At least 50 % attempts period unsuccessful accord subject diary . Presence penile anatomical abnormality ( eg penile fibrosis Peyronie 's disease ) investigator 's opinion would significantly impair sexual performance . Primary hypoactive sexual desire.Spinal cord injuryHistory surgical prostatectomy ( transurethral intervention exclude ) . Unstable angina pectoris . History myocardial infarction , stroke lifethreatening arrhythmia within prior 6 month . Uncontrolled atrial fibrillation/flutter screen visit ( ventricular response rate &gt; 100 BPM ) .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>Vardenafil</keyword>
	<keyword>Erectile dysfunction</keyword>
	<keyword>SSES-E ( sexual self-efficacy scale - erectile function )</keyword>
</DOC>